Click for best price
Cognitive Impairment Disorders Treatment Market Size, Share 2023
This report contains market size and forecasts of Cognitive Impairment Disorders Treatment in Global, including the following market information:
Global Cognitive Impairment Disorders Treatment Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cognitive Impairment Disorders Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Antiepileptic Drugs Cognitive Impairment Disorders Treatment Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Cognitive Impairment Disorders Treatment include Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb, Pfizer, Minerva Neurosciences, Intra-Cellular Therapies, Avineuro Pharmaceuticals, SyneuRx and Lundbeck, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cognitive Impairment Disorders Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cognitive Impairment Disorders Treatment Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Cognitive Impairment Disorders Treatment Market Segment Percentages, by Type, 2022 (%)
Antiepileptic Drugs Cognitive Impairment Disorders Treatment
Antipsychotics Drugs Cognitive Impairment Disorders Treatment
Global Cognitive Impairment Disorders Treatment Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Cognitive Impairment Disorders Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Specialty Clinics
Retail Pharmacies
Others
Global Cognitive Impairment Disorders Treatment Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Cognitive Impairment Disorders Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cognitive Impairment Disorders Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cognitive Impairment Disorders Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Pfizer
Minerva Neurosciences
Intra-Cellular Therapies
Avineuro Pharmaceuticals
SyneuRx
Lundbeck
AB Science SA
AbbVie Inc
CHA Bio & Diostech Co Ltd
Echo Pharmaceuticals BV
Eisai Co Ltd
GlaxoSmithKline Plc
Grifols SA
Immungenetics AG
Otsuka Holdings Co Ltd
Merck & Co Inc
Kyowa Hakko Kirin Co Ltd
| Report Attributes |
Report Details |
| Report Title |
Cognitive Impairment Disorders Treatment Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
110 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cognitive Impairment Disorders Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cognitive Impairment Disorders Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cognitive Impairment Disorders Treatment Overall Market Size
2.1 Global Cognitive Impairment Disorders Treatment Market Size: 2022 VS 2030
2.2 Global Cognitive Impairment Disorders Treatment Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cognitive Impairment Disorders Treatment Players in Global Market
3.2 Top Global Cognitive Impairment Disorders Treatment Companies Ranked by Revenue
3.3 Global Cognitive Impairment Disorders Treatment Revenue by Companies
3.4 Top 3 and Top 5 Cognitive Impairment Disorders Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cognitive Impairment Disorders Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cognitive Impairment Disorders Treatment Players in Global Market
3.6.1 List of Global Tier 1 Cognitive Impairment Disorders Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Cognitive Impairment Disorders Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cognitive Impairment Disorders Treatment Market Size Markets, 2022 & 2030
4.1.2 Antiepileptic Drugs Cognitive Impairment Disorders Treatment
4.1.3 Antipsychotics Drugs Cognitive Impairment Disorders Treatment
4.2 By Type - Global Cognitive Impairment Disorders Treatment Revenue & Forecasts
4.2.1 By Type - Global Cognitive Impairment Disorders Treatment Revenue, 2018-2023
4.2.2 By Type - Global Cognitive Impairment Disorders Treatment Revenue, 2023-2030
4.2.3 By Type - Global Cognitive Impairment Disorders Treatment Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cognitive Impairment Disorders Treatment Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Specialty Clinics
5.1.4 Retail Pharmacies
5.1.5 Others
5.2 By Application - Global Cognitive Impairment Disorders Treatment Revenue & Forecasts
5.2.1 By Application - Global Cognitive Impairment Disorders Treatment Revenue, 2018-2023
5.2.2 By Application - Global Cognitive Impairment Disorders Treatment Revenue, 2023-2030
5.2.3 By Application - Global Cognitive Impairment Disorders Treatment Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cognitive Impairment Disorders Treatment Market Size, 2022 & 2030
6.2 By Region - Global Cognitive Impairment Disorders Treatment Revenue & Forecasts
6.2.1 By Region - Global Cognitive Impairment Disorders Treatment Revenue, 2018-2023
6.2.2 By Region - Global Cognitive Impairment Disorders Treatment Revenue, 2023-2030
6.2.3 By Region - Global Cognitive Impairment Disorders Treatment Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cognitive Impairment Disorders Treatment Revenue, 2018-2030
6.3.2 US Cognitive Impairment Disorders Treatment Market Size, 2018-2030
6.3.3 Canada Cognitive Impairment Disorders Treatment Market Size, 2018-2030
6.3.4 Mexico Cognitive Impairment Disorders Treatment Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cognitive Impairment Disorders Treatment Revenue, 2018-2030
6.4.2 Germany Cognitive Impairment Disorders Treatment Market Size, 2018-2030
6.4.3 France Cognitive Impairment Disorders Treatment Market Size, 2018-2030
6.4.4 U.K. Cognitive Impairment Disorders Treatment Market Size, 2018-2030
6.4.5 Italy Cognitive Impairment Disorders Treatment Market Size, 2018-2030
6.4.6 Russia Cognitive Impairment Disorders Treatment Market Size, 2018-2030
6.4.7 Nordic Countries Cognitive Impairment Disorders Treatment Market Size, 2018-2030
6.4.8 Benelux Cognitive Impairment Disorders Treatment Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cognitive Impairment Disorders Treatment Revenue, 2018-2030
6.5.2 China Cognitive Impairment Disorders Treatment Market Size, 2018-2030
6.5.3 Japan Cognitive Impairment Disorders Treatment Market Size, 2018-2030
6.5.4 South Korea Cognitive Impairment Disorders Treatment Market Size, 2018-2030
6.5.5 Southeast Asia Cognitive Impairment Disorders Treatment Market Size, 2018-2030
6.5.6 India Cognitive Impairment Disorders Treatment Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cognitive Impairment Disorders Treatment Revenue, 2018-2030
6.6.2 Brazil Cognitive Impairment Disorders Treatment Market Size, 2018-2030
6.6.3 Argentina Cognitive Impairment Disorders Treatment Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cognitive Impairment Disorders Treatment Revenue, 2018-2030
6.7.2 Turkey Cognitive Impairment Disorders Treatment Market Size, 2018-2030
6.7.3 Israel Cognitive Impairment Disorders Treatment Market Size, 2018-2030
6.7.4 Saudi Arabia Cognitive Impairment Disorders Treatment Market Size, 2018-2030
6.7.5 UAE Cognitive Impairment Disorders Treatment Market Size, 2018-2030
7 Players Profiles
7.1 Eli Lilly and Company
7.1.1 Eli Lilly and Company Corporate Summary
7.1.2 Eli Lilly and Company Business Overview
7.1.3 Eli Lilly and Company Cognitive Impairment Disorders Treatment Major Product Offerings
7.1.4 Eli Lilly and Company Cognitive Impairment Disorders Treatment Revenue in Global Market (2018-2023)
7.1.5 Eli Lilly and Company Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Cognitive Impairment Disorders Treatment Major Product Offerings
7.2.4 AstraZeneca Cognitive Impairment Disorders Treatment Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca Key News
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Corporate Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Cognitive Impairment Disorders Treatment Major Product Offerings
7.3.4 Bristol-Myers Squibb Cognitive Impairment Disorders Treatment Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Cognitive Impairment Disorders Treatment Major Product Offerings
7.4.4 Pfizer Cognitive Impairment Disorders Treatment Revenue in Global Market (2018-2023)
7.4.5 Pfizer Key News
7.5 Minerva Neurosciences
7.5.1 Minerva Neurosciences Corporate Summary
7.5.2 Minerva Neurosciences Business Overview
7.5.3 Minerva Neurosciences Cognitive Impairment Disorders Treatment Major Product Offerings
7.5.4 Minerva Neurosciences Cognitive Impairment Disorders Treatment Revenue in Global Market (2018-2023)
7.5.5 Minerva Neurosciences Key News
7.6 Intra-Cellular Therapies
7.6.1 Intra-Cellular Therapies Corporate Summary
7.6.2 Intra-Cellular Therapies Business Overview
7.6.3 Intra-Cellular Therapies Cognitive Impairment Disorders Treatment Major Product Offerings
7.6.4 Intra-Cellular Therapies Cognitive Impairment Disorders Treatment Revenue in Global Market (2018-2023)
7.6.5 Intra-Cellular Therapies Key News
7.7 Avineuro Pharmaceuticals
7.7.1 Avineuro Pharmaceuticals Corporate Summary
7.7.2 Avineuro Pharmaceuticals Business Overview
7.7.3 Avineuro Pharmaceuticals Cognitive Impairment Disorders Treatment Major Product Offerings
7.7.4 Avineuro Pharmaceuticals Cognitive Impairment Disorders Treatment Revenue in Global Market (2018-2023)
7.7.5 Avineuro Pharmaceuticals Key News
7.8 SyneuRx
7.8.1 SyneuRx Corporate Summary
7.8.2 SyneuRx Business Overview
7.8.3 SyneuRx Cognitive Impairment Disorders Treatment Major Product Offerings
7.8.4 SyneuRx Cognitive Impairment Disorders Treatment Revenue in Global Market (2018-2023)
7.8.5 SyneuRx Key News
7.9 Lundbeck
7.9.1 Lundbeck Corporate Summary
7.9.2 Lundbeck Business Overview
7.9.3 Lundbeck Cognitive Impairment Disorders Treatment Major Product Offerings
7.9.4 Lundbeck Cognitive Impairment Disorders Treatment Revenue in Global Market (2018-2023)
7.9.5 Lundbeck Key News
7.10 AB Science SA
7.10.1 AB Science SA Corporate Summary
7.10.2 AB Science SA Business Overview
7.10.3 AB Science SA Cognitive Impairment Disorders Treatment Major Product Offerings
7.10.4 AB Science SA Cognitive Impairment Disorders Treatment Revenue in Global Market (2018-2023)
7.10.5 AB Science SA Key News
7.11 AbbVie Inc
7.11.1 AbbVie Inc Corporate Summary
7.11.2 AbbVie Inc Business Overview
7.11.3 AbbVie Inc Cognitive Impairment Disorders Treatment Major Product Offerings
7.11.4 AbbVie Inc Cognitive Impairment Disorders Treatment Revenue in Global Market (2018-2023)
7.11.5 AbbVie Inc Key News
7.12 CHA Bio & Diostech Co Ltd
7.12.1 CHA Bio & Diostech Co Ltd Corporate Summary
7.12.2 CHA Bio & Diostech Co Ltd Business Overview
7.12.3 CHA Bio & Diostech Co Ltd Cognitive Impairment Disorders Treatment Major Product Offerings
7.12.4 CHA Bio & Diostech Co Ltd Cognitive Impairment Disorders Treatment Revenue in Global Market (2018-2023)
7.12.5 CHA Bio & Diostech Co Ltd Key News
7.13 Echo Pharmaceuticals BV
7.13.1 Echo Pharmaceuticals BV Corporate Summary
7.13.2 Echo Pharmaceuticals BV Business Overview
7.13.3 Echo Pharmaceuticals BV Cognitive Impairment Disorders Treatment Major Product Offerings
7.13.4 Echo Pharmaceuticals BV Cognitive Impairment Disorders Treatment Revenue in Global Market (2018-2023)
7.13.5 Echo Pharmaceuticals BV Key News
7.14 Eisai Co Ltd
7.14.1 Eisai Co Ltd Corporate Summary
7.14.2 Eisai Co Ltd Business Overview
7.14.3 Eisai Co Ltd Cognitive Impairment Disorders Treatment Major Product Offerings
7.14.4 Eisai Co Ltd Cognitive Impairment Disorders Treatment Revenue in Global Market (2018-2023)
7.14.5 Eisai Co Ltd Key News
7.15 GlaxoSmithKline Plc
7.15.1 GlaxoSmithKline Plc Corporate Summary
7.15.2 GlaxoSmithKline Plc Business Overview
7.15.3 GlaxoSmithKline Plc Cognitive Impairment Disorders Treatment Major Product Offerings
7.15.4 GlaxoSmithKline Plc Cognitive Impairment Disorders Treatment Revenue in Global Market (2018-2023)
7.15.5 GlaxoSmithKline Plc Key News
7.16 Grifols SA
7.16.1 Grifols SA Corporate Summary
7.16.2 Grifols SA Business Overview
7.16.3 Grifols SA Cognitive Impairment Disorders Treatment Major Product Offerings
7.16.4 Grifols SA Cognitive Impairment Disorders Treatment Revenue in Global Market (2018-2023)
7.16.5 Grifols SA Key News
7.17 Immungenetics AG
7.17.1 Immungenetics AG Corporate Summary
7.17.2 Immungenetics AG Business Overview
7.17.3 Immungenetics AG Cognitive Impairment Disorders Treatment Major Product Offerings
7.17.4 Immungenetics AG Cognitive Impairment Disorders Treatment Revenue in Global Market (2018-2023)
7.17.5 Immungenetics AG Key News
7.18 Otsuka Holdings Co Ltd
7.18.1 Otsuka Holdings Co Ltd Corporate Summary
7.18.2 Otsuka Holdings Co Ltd Business Overview
7.18.3 Otsuka Holdings Co Ltd Cognitive Impairment Disorders Treatment Major Product Offerings
7.18.4 Otsuka Holdings Co Ltd Cognitive Impairment Disorders Treatment Revenue in Global Market (2018-2023)
7.18.5 Otsuka Holdings Co Ltd Key News
7.19 Merck & Co Inc
7.19.1 Merck & Co Inc Corporate Summary
7.19.2 Merck & Co Inc Business Overview
7.19.3 Merck & Co Inc Cognitive Impairment Disorders Treatment Major Product Offerings
7.19.4 Merck & Co Inc Cognitive Impairment Disorders Treatment Revenue in Global Market (2018-2023)
7.19.5 Merck & Co Inc Key News
7.20 Kyowa Hakko Kirin Co Ltd
7.20.1 Kyowa Hakko Kirin Co Ltd Corporate Summary
7.20.2 Kyowa Hakko Kirin Co Ltd Business Overview
7.20.3 Kyowa Hakko Kirin Co Ltd Cognitive Impairment Disorders Treatment Major Product Offerings
7.20.4 Kyowa Hakko Kirin Co Ltd Cognitive Impairment Disorders Treatment Revenue in Global Market (2018-2023)
7.20.5 Kyowa Hakko Kirin Co Ltd Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cognitive Impairment Disorders Treatment Market Opportunities & Trends in Global Market
Table 2. Cognitive Impairment Disorders Treatment Market Drivers in Global Market
Table 3. Cognitive Impairment Disorders Treatment Market Restraints in Global Market
Table 4. Key Players of Cognitive Impairment Disorders Treatment in Global Market
Table 5. Top Cognitive Impairment Disorders Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cognitive Impairment Disorders Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cognitive Impairment Disorders Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cognitive Impairment Disorders Treatment Product Type
Table 9. List of Global Tier 1 Cognitive Impairment Disorders Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cognitive Impairment Disorders Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Cognitive Impairment Disorders Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cognitive Impairment Disorders Treatment Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Cognitive Impairment Disorders Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cognitive Impairment Disorders Treatment Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Cognitive Impairment Disorders Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cognitive Impairment Disorders Treatment Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2023-2030
Table 30. Eli Lilly and Company Corporate Summary
Table 31. Eli Lilly and Company Cognitive Impairment Disorders Treatment Product Offerings
Table 32. Eli Lilly and Company Cognitive Impairment Disorders Treatment Revenue (US$, Mn), (2018-2023)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Cognitive Impairment Disorders Treatment Product Offerings
Table 35. AstraZeneca Cognitive Impairment Disorders Treatment Revenue (US$, Mn), (2018-2023)
Table 36. Bristol-Myers Squibb Corporate Summary
Table 37. Bristol-Myers Squibb Cognitive Impairment Disorders Treatment Product Offerings
Table 38. Bristol-Myers Squibb Cognitive Impairment Disorders Treatment Revenue (US$, Mn), (2018-2023)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Cognitive Impairment Disorders Treatment Product Offerings
Table 41. Pfizer Cognitive Impairment Disorders Treatment Revenue (US$, Mn), (2018-2023)
Table 42. Minerva Neurosciences Corporate Summary
Table 43. Minerva Neurosciences Cognitive Impairment Disorders Treatment Product Offerings
Table 44. Minerva Neurosciences Cognitive Impairment Disorders Treatment Revenue (US$, Mn), (2018-2023)
Table 45. Intra-Cellular Therapies Corporate Summary
Table 46. Intra-Cellular Therapies Cognitive Impairment Disorders Treatment Product Offerings
Table 47. Intra-Cellular Therapies Cognitive Impairment Disorders Treatment Revenue (US$, Mn), (2018-2023)
Table 48. Avineuro Pharmaceuticals Corporate Summary
Table 49. Avineuro Pharmaceuticals Cognitive Impairment Disorders Treatment Product Offerings
Table 50. Avineuro Pharmaceuticals Cognitive Impairment Disorders Treatment Revenue (US$, Mn), (2018-2023)
Table 51. SyneuRx Corporate Summary
Table 52. SyneuRx Cognitive Impairment Disorders Treatment Product Offerings
Table 53. SyneuRx Cognitive Impairment Disorders Treatment Revenue (US$, Mn), (2018-2023)
Table 54. Lundbeck Corporate Summary
Table 55. Lundbeck Cognitive Impairment Disorders Treatment Product Offerings
Table 56. Lundbeck Cognitive Impairment Disorders Treatment Revenue (US$, Mn), (2018-2023)
Table 57. AB Science SA Corporate Summary
Table 58. AB Science SA Cognitive Impairment Disorders Treatment Product Offerings
Table 59. AB Science SA Cognitive Impairment Disorders Treatment Revenue (US$, Mn), (2018-2023)
Table 60. AbbVie Inc Corporate Summary
Table 61. AbbVie Inc Cognitive Impairment Disorders Treatment Product Offerings
Table 62. AbbVie Inc Cognitive Impairment Disorders Treatment Revenue (US$, Mn), (2018-2023)
Table 63. CHA Bio & Diostech Co Ltd Corporate Summary
Table 64. CHA Bio & Diostech Co Ltd Cognitive Impairment Disorders Treatment Product Offerings
Table 65. CHA Bio & Diostech Co Ltd Cognitive Impairment Disorders Treatment Revenue (US$, Mn), (2018-2023)
Table 66. Echo Pharmaceuticals BV Corporate Summary
Table 67. Echo Pharmaceuticals BV Cognitive Impairment Disorders Treatment Product Offerings
Table 68. Echo Pharmaceuticals BV Cognitive Impairment Disorders Treatment Revenue (US$, Mn), (2018-2023)
Table 69. Eisai Co Ltd Corporate Summary
Table 70. Eisai Co Ltd Cognitive Impairment Disorders Treatment Product Offerings
Table 71. Eisai Co Ltd Cognitive Impairment Disorders Treatment Revenue (US$, Mn), (2018-2023)
Table 72. GlaxoSmithKline Plc Corporate Summary
Table 73. GlaxoSmithKline Plc Cognitive Impairment Disorders Treatment Product Offerings
Table 74. GlaxoSmithKline Plc Cognitive Impairment Disorders Treatment Revenue (US$, Mn), (2018-2023)
Table 75. Grifols SA Corporate Summary
Table 76. Grifols SA Cognitive Impairment Disorders Treatment Product Offerings
Table 77. Grifols SA Cognitive Impairment Disorders Treatment Revenue (US$, Mn), (2018-2023)
Table 78. Immungenetics AG Corporate Summary
Table 79. Immungenetics AG Cognitive Impairment Disorders Treatment Product Offerings
Table 80. Immungenetics AG Cognitive Impairment Disorders Treatment Revenue (US$, Mn), (2018-2023)
Table 81. Otsuka Holdings Co Ltd Corporate Summary
Table 82. Otsuka Holdings Co Ltd Cognitive Impairment Disorders Treatment Product Offerings
Table 83. Otsuka Holdings Co Ltd Cognitive Impairment Disorders Treatment Revenue (US$, Mn), (2018-2023)
Table 84. Merck & Co Inc Corporate Summary
Table 85. Merck & Co Inc Cognitive Impairment Disorders Treatment Product Offerings
Table 86. Merck & Co Inc Cognitive Impairment Disorders Treatment Revenue (US$, Mn), (2018-2023)
Table 87. Kyowa Hakko Kirin Co Ltd Corporate Summary
Table 88. Kyowa Hakko Kirin Co Ltd Cognitive Impairment Disorders Treatment Product Offerings
Table 89. Kyowa Hakko Kirin Co Ltd Cognitive Impairment Disorders Treatment Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Cognitive Impairment Disorders Treatment Segment by Type in 2022
Figure 2. Cognitive Impairment Disorders Treatment Segment by Application in 2022
Figure 3. Global Cognitive Impairment Disorders Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cognitive Impairment Disorders Treatment Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cognitive Impairment Disorders Treatment Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cognitive Impairment Disorders Treatment Revenue in 2022
Figure 8. By Type - Global Cognitive Impairment Disorders Treatment Revenue Market Share, 2018-2030
Figure 9. By Application - Global Cognitive Impairment Disorders Treatment Revenue Market Share, 2018-2030
Figure 10. By Region - Global Cognitive Impairment Disorders Treatment Revenue Market Share, 2018-2030
Figure 11. By Country - North America Cognitive Impairment Disorders Treatment Revenue Market Share, 2018-2030
Figure 12. US Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Cognitive Impairment Disorders Treatment Revenue Market Share, 2018-2030
Figure 16. Germany Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 17. France Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Cognitive Impairment Disorders Treatment Revenue Market Share, 2018-2030
Figure 24. China Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 28. India Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Cognitive Impairment Disorders Treatment Revenue Market Share, 2018-2030
Figure 30. Brazil Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Cognitive Impairment Disorders Treatment Revenue Market Share, 2018-2030
Figure 33. Turkey Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Cognitive Impairment Disorders Treatment Revenue, (US$, Mn), 2018-2030
Figure 37. Eli Lilly and Company Cognitive Impairment Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. AstraZeneca Cognitive Impairment Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Bristol-Myers Squibb Cognitive Impairment Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Pfizer Cognitive Impairment Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Minerva Neurosciences Cognitive Impairment Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Intra-Cellular Therapies Cognitive Impairment Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Avineuro Pharmaceuticals Cognitive Impairment Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. SyneuRx Cognitive Impairment Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Lundbeck Cognitive Impairment Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AB Science SA Cognitive Impairment Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AbbVie Inc Cognitive Impairment Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. CHA Bio & Diostech Co Ltd Cognitive Impairment Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Echo Pharmaceuticals BV Cognitive Impairment Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Eisai Co Ltd Cognitive Impairment Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. GlaxoSmithKline Plc Cognitive Impairment Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Grifols SA Cognitive Impairment Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Immungenetics AG Cognitive Impairment Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Otsuka Holdings Co Ltd Cognitive Impairment Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Merck & Co Inc Cognitive Impairment Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Kyowa Hakko Kirin Co Ltd Cognitive Impairment Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
